A roadmap for grapheneKostya S. Novoselov, K. Kim, Vladimir I. Fal’ko et al.|Nature|2012Cited by 9.1k
A 12-gene pharmacogenetic panel to prevent adverse drug reactions: an open-label, multicentre, controlled, cluster-randomised crossover implementation studyJesse J. Swen, Roelof Bosch, Cathelijne H. van der Wouden et al.|The Lancet|2023Cited by 508
Dihydropyrimidine Dehydrogenase Testing prior to Treatment with 5-Fluorouracil, Capecitabine, and Tegafur: A Consensus PaperBernhard Wörmann, Ralf‐Dieter Hofheinz, Jens‐Uwe Blohmer et al.|Oncology Research and Treatment|2020Cited by 88